Parkinson's Disease Clinical Trials in Los Angeles

Showing 21-40 of 109 trials

STEM-PD Open Label Extension (OLE)

NCT04799418

This study seeks to establish the safety and efficacy of extended twice daily time-varying caloric vestibular stimulation treatments for treating symptoms associated with Parkinson's disease. Only participants who completed the STEM-PD randomized controlled trial portion (NCT04797611) are eligible to participate in the open label extension portion.

Parkinson DiseaseParkinson's Disease and Parkinsonism

Scion NeuroStim148 participantsStarted Sep 2022

Scottsdale, Arizona, United States • Los Angeles, California, United States • Boca Raton, Florida, United States +12 more locations

RECRUITINGNA< 1 mile

Evaluation of Neurocognitive Changes in Parkinson's Disease After Low Frequency Burst Stimulation

NCT05307055

This study aims to determine whether direct brain stimulation of specific regions and ranges improves cognition in people with Parkinsons Disease (PD) who already have a deep brain stimulator implanted. Research activities consist of 32 subjects undergoing stimulation changes to their device and being administered neurocognitive tests to evaluate the changes. An fMRI scan will also be done at baseline and at weeks 15 and 27. All subjects will undergo the stimulation changes in a randomized double blind crossover study. Evaluation of stimulation changes will be assessed through analysis of neurocognitive data.

Parkinson Disease

University of Southern California40 participantsStarted Jan 2022

Los Angeles, California, United States

STEM-PD Open Label Extension (OLE)

Evaluation of Neurocognitive Changes in Parkinson's Disease After Low Frequency Burst Stimulation

Parkinson's Disease Trials in Other Cities

Parkinson's Foundation PD GENEration Genetic Registry

STEM-Parkinson's Disease

North American Prodromal Synucleinopathy Consortium

A Study of TAK-071 in People With Parkinson Disease

Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease

Safety and Efficacy of Liraglutide in Parkinson's Disease

Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation

Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease

Deep Brain Stimulation (DBS) for the Treatment of Parkinson's Disease

Orally Administered ENT-01 for Parkinson's Disease-Related Constipation Follow-on Safety "Roll-over" Study (Rollover)

Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET)

Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis

A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD

A Study to Evaluate the Safety and Tolerability of ABBV-951 in Subjects With Parkinson's Disease (PD)

Clinical Outcome Assessment of Parkinson's Disease Patients Treated With XADAGO (Safinamide)

Wearable Assessments in the Clinic and Home in PD

Clinical Evaluation of the Infinity Deep Brain Stimulation System

Posiphen® Dose-Finding, Biomarker Study in Early Alzheimer's and Parkinson's Patients

Other Conditions in Los Angeles